Skip to main content

An Unprecedented Discussion with the FDA on Nov 3 - Please Join at diabetestownhall2014

Updated: 8/14/21 8:00 amPublished: 10/23/14

twitter summary: what's impt. for #diabetes, tell the @US_FDA your thoughts at

On November 3, the FDA will host an unprecedented discussion between the diabetes community and its senior agency leadership (both drugs and devices). The event will be live webcasted from 1 - 4 pm (please join here), and will include a panel of people with type 1 and type 2 diabetes, as well as representatives from ADA, JDRF, and diaTribe. 

As a community of people touched by diabetes, we have a huge opportunity to present the numerous challenges we face each day, and we need as many opinions as possible to be a part of this discussion! With ADA, JDRF, and dQ&A input, we have created a survey posted at We are asking the entire diabetes community (type 1, type 2, gestational, caregivers, etc.) to please fill out this short survey and share thoughts on what's important when it comes to living with diabetes. This feedback will go DIRECTLY to the FDA and help influence the conversation on November 3. Thank you to the more than 7,500 people who have answered the survey so far.

To ensure the perspectives of the largest segment of the community are represented, we need your help in spreading the word! Every little bit counts, so if you know someone with diabetes who'd be interested in this survey, please share the link:! Below find a few sample tweets we’ve drafted:

To join in, please go to this link. We need to show the FDA that patients care about these issues, that patients have valuable input to share, and that the treatment options we have are still not good enough. Please join the discussion at #DOCasksFDA on Twitter and share what you want to see from the FDA with your own video! -AB

For more information or for media inquiries, please contact the diaTribe Managing Editor, Nancy Liu, at 415-241-9500 or [email protected].


What do you think?